Related Compounds
Compounds connected by the same goals, effects, or research topics.
Herb Profile
Ginkgo biloba
Ginkgo biloba is one of the oldest surviving tree species; standardized leaf extracts such as EGb 761 supply flavonoid glycosides and terpene lactones and are marketed for memory and circulation.
Use extra caution — Raises bleeding risk when combined with anticoagulants, antiplatelets, or NSAIDs (aspirin, clopidogrel); may lower the seizure threshold and reduce the effectiveness of seizure medication, so avoid combining with anti seizure drugs. Details

Best for
Not ideal for
Safety: Ginkgo raises bleeding risk, so it warrants clinician review with anticoagulants, antiplatelets, or upcoming surgery. It may lower the seizure threshold. Raw or roasted ginkgo seeds are toxic and are not the same thing as leaf extract.
On the evidence: Large randomized trials support modest benefit in existing cognitive impairment; the major dementia-prevention trials in healthy adults were negative.
Why not higher
Why not lower
Practical takeaway: Reasonable to trial as standardized extract when cognitive complaints already exist and bleeding risk has been cleared. Not a sensible dementia-prevention strategy for a healthy adult.
Start here
New to this? Begin with Best nootropics for focus.
Continue reading
Safety
Raises bleeding risk when combined with anticoagulants, antiplatelets, or NSAIDs (aspirin, clopidogrel); may lower the seizure threshold and reduce the effectiveness of seizure medication, so avoid combining with anti seizure drugs. Discontinue at least two weeks before elective surgery; raw or roasted ginkgo seeds contain ginkgotoxin and are a distinct seizure risk from the extract.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
Evidence-based safety
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
Serotonergic activity · Bleeding / anticoagulant risk
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Data provenance recorded for 26 of 26 pairings in this mechanism group.
+14 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Data provenance recorded for 147 of 147 pairings in this mechanism group.
+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Useful signal, but study design, dose, and population still matter.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Vascular Function Support · Neuroprotective Activity
Research maturity: Established research — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — Raises bleeding risk when combined with anticoagulants, antiplatelets, or NSAIDs (aspirin, clopidogrel); may lower the seizure threshold and reduce the effectiveness of seizure medication, so avoid combining with anti se
This profile cites 3 human studies.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Filter by study class
Showing 7 of 7 studies.
What the evidence actually shows
This table contains 7 structured sources, including 5 human evidence sources; 1 is a human trial. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.
Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned
What would change our conclusion?
Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | Pooled randomized data favored EGb 761 for cognition, activities of daily living, and global clinical impression. | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | EGb 761 240 mg/day favored cognition, global impression, activities of daily living, and quality of life. | PubMed → |
Warfarin and food, herbal or dietary supplement interactions: A systematic review Tan CSS et al. · Br J Clin Pharmacol · 2021 Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | — | PubMed → |
Plant-derived nootropics and human cognition: A systematic review Lorca C et al. · Crit Rev Food Sci Nutr · 2023 Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | — | PubMed → |
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | Health Benefits of a Standardized Ginkgo biloba Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials | PubMed → |
Singh SK et al. · Neurotherapeutics · 2019 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Ginkgo biloba for cognitive impairment and dementia Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | For dementia, low-certainty evidence suggested small-to-moderate benefits; for MCI, ginkgo had little or no clear effect. | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Ginkgo Works
Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.
Key constituents studied in Ginkgo, with full pharmacology and safety profiles.
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Condition guides
Compare side-by-side tradeoffs or verify active marker guidelines.
Sourcing options
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
When sourcing Ginkgo, verify the label for:
Continue comparing
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Botanical profile context
Ginkgo herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.
When reviewing Ginkgo, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.
For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.